Doses de nitrogênio e potássio em fertirrigação em maracujazeiro-amarelo consorciado com coqueiro-anão verde, na região Norte Fluminense

Com o objetivo de avaliar os efeitos de doses de nitrogênio (N) e potássio (K) na água de irrigação, sobre a produtividade e os teores foliares de nutrientes minerais em maracujazeiro-amarelo consorciado com coqueiro-anão verde no Norte Fluminense, foi instalado um experimento em delineamento inteiramente casualizado, com 2 tratamentos (2 doses de adubação, em fertirrigação: 1) N=161 e K=215 kg ha-1 ano-1, e 2) N=322 e K=430 kg ha-1 ano-1) e 12 repetições, em um solo classificado como Neossolo Quartzarênico. As plantas foram irrigadas por microaspersão, com emissores com vazão de 60 L hora-1, sendo um para cada pé de coco com quatro pés de maracujá, utilizando lâmina de 75% de Et0. A injeção do fertilizante foi feita por injetor do tipo Venturi. As unidades experimentais constaram de 5 plantas de coco e 20 de maracujá. Realizaram-se 5 amostragens foliares no maracujazeiro, com intervalos trimestrais. As amostras consistiram de 20 folhas recém-maduras, coletando-se a 5ª folha do ápice para a base do ramo. Determinaram-se os teores de N, P, K, Ca, Mg, S, Cl, Na, Fe, Zn, Cu, Mn e B. As doses de N e K não influenciaram na produtividade e no peso médio do fruto; apenas, os teores foliares de N, Ca e Zn, em algumas épocas de amostragem.

Desempenho produtivo de mudas nacionais e importadas de morangueiro

O objetivo deste trabalho foi avaliar o desempenho produtivo de mudas nacionais e importadas de morangueiro das cultivares Aromas e Camarosa, nas condições climáticas de Pelotas. O experimento foi realizado utilizando sistema de produção sob túnel, irrigação por gotejamento e adubação fornecida via água de irrigação. O transplantio das mudas foi realizado em junho de 2005, num espaçamento de 35 cm entre linhas e entre plantas. Utilizaram-se mudas de duas cultivares (Aromas e Camarosa) e de três procedências (Chile, Serra Gaúcha e região de Pelotas). Os tratamentos foram dispostos em delineamento de blocos ao acaso, em esquema fatorial com quatro repetições. As unidades experimentais foram constituídas por 20 plantas. Semanalmente, de agosto a dezembro, foram analisadas as variáveis número e massa fresca de frutos. A cv. Camarosa (569,6 g planta-1) foi mais produtiva do que a 'Aromas' (510,4 g planta-1). Independentemente da cultivar, as mudas importadas do Chile proporcionaram maior produção de frutos comerciais (724,5 g planta-1) e frutos de maior massa (15,5 g) do que as mudas produzidas na região de Pelotas (493,3 planta-1 e 12,6 g fruto-1) e na Serra Gaúcha (402,3 g planta-1 e 11,7 g fruto-1).

The border of reproductive control: undocumented immigration as a risk factor for unintended pregnancy in Switzerland.

Unintended pregnancies reflect an unmet need for family planning, and are part of health disparities. Using the only database to inquire about pregnancy intention among women in Switzerland, this study examined the relationship between immigrant documentation and unintended pregnancy (UP). Among pregnant women presenting to a Swiss hospital, we compared pregnancy intention between documented and undocumented women. We used logistic regression to examine whether undocumented status was associated with UP after adjusting for other significant predictors. Undocumented women had more unintended pregnancies (75.2 vs. 20.6 %, p = 0.00). Undocumented status was associated with UP after adjustment (OR 6.23, 95 % CI 1.83-21.2), as was a history of psychological problems (OR 4.09, 95 % CI 1.32-12.7). Contraception non-use was notably associated with lower odds of UP (OR 0.01, 95 % CI 0.004-0.04). Undocumented status was significantly associated with UP, even after adjusting for well-recognized risk factors. This highlights the tremendous risk of undocumented status on UP among women in Switzerland.

Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

This multicenter, observational prospective cohort study addresses the risk associated with exposure to mirtazapine during pregnancy. Pregnancy outcomes after exposure to mirtazapine were compared with 2 matched control groups: (1) exposure to any selective serotonin reuptake inhibitor (SSRI, control subjects with a psychiatric condition) and (2) no exposure to medication known to be teratogenic or any antidepressant (general control subjects). Data were collected by members of the European Network of Teratology Information Services between 1995 and 2011. Observations from 357 exposed pregnancies were compared with 357 pregnancies from each control group. The rate of major birth defects between the mirtazapine and the SSRI group did not differ significantly (4.5% vs 4.2%; odds ratio [OR], 1.1; 95% confidence interval [95% CI], 0.5-2.3; P = 0.9). A trend toward a higher rate of birth defects in the mirtazapine group compared with general control subjects (4.5% vs 1.9%; OR, 2.4; 95% CI, 0.9-6.3; P = 0.08) reached statistical significance after exclusion of chromosomal or genetic anomalies (4.1% vs 1.3%; OR, 3.3; 95% CI, 1.04-10.3; P = 0.03), but this difference became again nonsignificant if cases of exposure not comprising the first trimester were excluded from the analysis (3.4% vs 1.9%; OR, 1.8; 95% CI, 0.6-5.0; P = 0.26). The crude miscarriage rate did not differ significantly between the mirtazapine, the SSRI, and the general control groups (12.1% vs 12.0% vs 9.3%; P = 0.44). However, a higher rate of elective pregnancy termination was observed in the mirtazapine group compared with SSRI and general control subjects (7.8% vs 3.4% vs 5.6%; P = 0.03). This study did not observe a statistically significant difference in the rate of major birth defects after first-trimester exposure between mirtazapine, SSRI-exposed, and nonexposed pregnancies. A marginally higher rate of birth defects was, however, observed in the mirtazapine and SSRI groups compared with the low rate of birth defects in our general control subjects. Overall pregnancy outcome after mirtazapine exposure was similar to that of the SSRI-exposed control group.

Relating microstructure, sensory and instrumental texture of processed oat

Selostus: Prosessoidun kauran mikroskooppinen ja aistittava rakenne

Composição de carotenoides em passifloras do cerrado

O objetivo foi avaliar, por HPLC, a composição qualitativa e quantitativa de carotenoides em maracujás do cerrado. Frutos procedentes de acessos nativos de quatro espécies (Passiflora cincinnata, P. nitida, P. setacea e P. edulis) foram analisados, utilizando, como referência, o maracujá-amarelo comercial (P. edulis). As polpas de maracujá apresentaram neoxantina, violaxantina, cis-violaxantina, anteraxantina, luteína, zeaxantina, β-criptoxantina, poli-cis-caroteno, prolicopeno, cis-ζ-caroteno, trans-ζ-caroteno, trans-β-caroteno, 13-cis-β-caroteno e fitoflueno. Em geral, os teores de carotenoides entre as espécies e entre os acessos da mesma espécie foram significativamente diferentes. A espécie P. edulis apresentou o maior número de carotenoides, com diferença entre os acessos. Em um acesso de P. edulis comercial, foi encontrado o trans-β-caroteno como o carotenoide principal (7,8±0,8 µg g-1) e no outro o trans-ζ-caroteno (11,4±0,4 µg g-1). Dois acessos de P. edulis nativos do Cerrado apresentaram cis-ζ-caroteno como carotenoide majoritário (6,28±0,15 µg g-1 e 12,1±0,7 µg g-1, casca amarela e roxa, respectivamente). O perfil de carotenoides em frutos de espécies de maracujá apresentou diversidade de composição, com potencial de uso para melhoramento genético para agregar maior valor ao produto e estimular o seu consumo.

The antilipolytic effect of insulin and epidermal growth factor in rat adipocytes are mediated by different mechanisms

Epidermal growth factor (EGF) and insulin induced similar effects in isolated rat adipocytes. To determine whether EGF and insulin produced similar effects through the same mechanisms, we focused on lipolysis. Insulin inhibited the lipolysis stimulated by isoproterenol, glucagon (either alone or in combination with adenosine deaminase), adenosine deaminase itself, or forskolin. In contrast, EGF did not inhibit the lipolysis stimulated by forskolin or by hormones when the cells were also incubated with adenosine deaminase. The effect of insulin, but not that of EGF, on isoproterenol-stimulated lipolysis disappeared when adipocytes were incubated with 1 microM wortmannin. These results indicate that EGF and insulin affected lipolysis through different mechanisms. We observed that EGF, but not insulin, increased cytosolic Ca2+. The effect of EGF, but not that of insulin, disappeared when the cells were incubated in a Ca2+-free medium. We suggest that EGF, but not insulin, mediate its antilipolytic effect through a Ca2+-dependent mechanism which, however, do not involve Ca2+-activated protein kinase C isoforms. This is based on the following: 1) phorbol 12-myristate 13-acetate affected lipolysis in an opposite way to that of EGF; and 2) the protein kinase C inhibitor bisindolylmaleimide GF 109203X did not affect the antilipolytic action of EGF. Our results indicate that the antilipolytic effect of EGF resembles more that of vasopressin than that of insulin.

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer

Background: As the long-term efficacy of stereotactic body radiation therapy (SBRT) becomes established and other prostate cancer treatment approaches are refined and improved, examination of quality of life (QOL) following prostate cancer treatment is critical in driving both patient and clinical treatment decisions. We present the first study to compare QOL after SBRT and radical prostatectomy, with QOL assessed at approximately the same times pre- and post-treatment and using the same validated QOL instrument. Methods: Patients with clinically localized prostate cancer were treated with either radical prostatectomy (n = 123 Spanish patients) or SBRT (n = 216 American patients). QOL was assessed using the Expanded Prostate Cancer Index Composite (EPIC) grouped into urinary, sexual, and bowel domains. For comparison purposes, SBRT EPIC data at baseline, 3 weeks, 5, 11, 24, and 36 months were compared to surgery data at baseline, 1, 6, 12, 24,and 36 months. Differences in patient characteristics between the two groups were assessed using Chi-squared tests for categorical variables and t-tests for continuous variables. Generalized estimating equation (GEE) models were constructed for each EPIC scale to account for correlation among repeated measures and used to assess the effect of treatment on QOL. Results: The largest differences in QOL occurred in the first 1-6 months after treatment, with larger declines following surgery in urinary and sexual QOL as compared to SBRT, and a larger decline in bowel QOL following SBRT as compared to surgery. Long-term urinary and sexual QOL declines remained clinically significantly lower for surgery patients but not for SBRT patients. Conclusions: Overall, these results may have implications for patient and physician clinical decision making which are often influenced by QOL. These differences in sexual, urinary and bowel QOL should be closely considered in selecting the right treatment, especially in evaluating the value of non-invasive treatments, such as SBRT.

Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study.

OBJECTIVE: To investigate the prevalence of discontinuation and nonpublication of surgical versus medical randomized controlled trials (RCTs) and to explore risk factors for discontinuation and nonpublication of surgical RCTs. BACKGROUND: Trial discontinuation has significant scientific, ethical, and economic implications. To date, the prevalence of discontinuation of surgical RCTs is unknown. METHODS: All RCT protocols approved between 2000 and 2003 by 6 ethics committees in Canada, Germany, and Switzerland were screened. Baseline characteristics were collected and, if published, full reports retrieved. Risk factors for early discontinuation for slow recruitment and nonpublication were explored using multivariable logistic regression analyses. RESULTS: In total, 863 RCT protocols involving adult patients were identified, 127 in surgery (15%) and 736 in medicine (85%). Surgical trials were discontinued for any reason more often than medical trials [43% vs 27%, risk difference 16% (95% confidence interval [CI]: 5%-26%); P = 0.001] and more often discontinued for slow recruitment [18% vs 11%, risk difference 8% (95% CI: 0.1%-16%); P = 0.020]. The percentage of trials not published as full journal article was similar in surgical and medical trials (44% vs 40%, risk difference 4% (95% CI: -5% to 14%); P = 0.373). Discontinuation of surgical trials was a strong risk factor for nonpublication (odds ratio = 4.18, 95% CI: 1.45-12.06; P = 0.008). CONCLUSIONS: Discontinuation and nonpublication rates were substantial in surgical RCTs and trial discontinuation was strongly associated with nonpublication. These findings need to be taken into account when interpreting surgical literature. Surgical trialists should consider feasibility studies before embarking on full-scale trials.

Acute stroke chameleons in a university hospital : Risk factors, circumstances, and outcomes.

OBJECTIVE: To identify risk factors, circumstances, and outcomes for individuals with acute ischemic stroke (AIS) chameleons (AIS-C) arriving in the emergency department of a university hospital. METHODS: We retrospectively reviewed all patients with AIS from the prospectively constructed Acute Stroke Registry and Analysis of Lausanne during 8.25 years. AIS-C were defined as a failure to suspect stroke or as incorrect exclusion of stroke diagnosis. They were compared with patients diagnosed correctly at the time of admission. RESULTS: Forty-seven of 2,200 AIS were missed (2.1%). These AIS-C were either very mild or very severe strokes. Multivariate analysis showed a younger age in patients with AIS-C (odds ratio [OR] per year 0.98, p < 0.01), less prestroke statin treatment (OR 0.29, p = 0.04), and lower diastolic admission blood pressure (OR 0.98 p = 0.04). They showed less eye deviation (OR 0.21, p = 0.04) and more cerebellar strokes (OR 3.78, p < 0.01). AIS-C were misdiagnosed as other neurologic (42.6% of cases) or nonneurologic (17.0%) disease, as unexplained decreased level of consciousness (21.3%), and as concomitantly present disease (19.1%). At 12 months, patients with AIS-C had less favorable outcomes (adjusted OR 0.21, p < 0.01) and higher mortality (adjusted OR 4.37, p < 0.01). CONCLUSIONS: AIS are missed in patients with younger age with a lower cerebrovascular risk profile and may be masked by other acute conditions. Patients with chameleons present more often with milder strokes or coma, fewer focal signs and cerebellar strokes, and have higher disability and mortality rates at 12 months. These findings may be used to raise awareness in emergency departments to recognize and treat such patients appropriately.

Optical spectroscopy of microquasar candidates at low Galactic latitudes

We report optical spectroscopic observations of a sample of 6 low-galactic latitude microquasar candidates selected by cross-identification of X-ray and radio point source catalogs for |b|<5 degrees. Two objects resulted to be of clear extragalactic origin, as an obvious cosmologic redshift has been measured from their emission lines. For the rest, none exhibits a clear stellar-like spectrum as would be expected for genuine Galactic microquasars. Their featureless spectra are consistent with being extragalactic in origin although two of them could be also highly reddened stars. The apparent non-confirmation of our candidates suggests that the population of persistent microquasar systems in the Galaxy is more rare than previously believed. If none of them is galactic, the upper limit to the space density of new Cygnus X-3-like microquasars within 15 kpc would be 1.1\times10^{-12} per cubic pc. A similar upper limit for new LS 5039-like systems within 4 kpc is estimated to be 5.6\times10^{-11} per cubic pc.

Vinouden huomioiva arvopapereiden hinnoittelumalli ja sen empiirinen testaaminen Suomen markkinoilla

Tutkimuksen tarkoituksena on tutkia osaketuottojen jakauman vinoutta ja sen mahdollisia vaikutuksia osakkeiden hinnoitteluun Suomen markkinoilla. Aineistona käytetään kuutta portfoliota jotka on muodostettu Suomen markkinoilla noteerattavista osakkeista ajanjaksolla 1.1.1987–31.12.2004. Osakkeet on jaettu portfolioihin markkina-arvon mukaan. Empiiriset tulokset osoittavat, että osaketuotot Suomen markkinoilla ovat positiivisesti vinoja mutta pääosin eivät merkitsevästi. Teoreettisen taustan perusteella olisi ollut odotettavaa, että vinoutta olisi ollut enemmän. Regressioanalyysillä ja kahta artikkelia replikoiden tutkittiin perinteisen ja vinouden sisältäviä CAPM-malleja. Odotettavissa oli, että perinteinen CAPM-malli suoriutuu huonommin kuin vinouden sisältävä. Regressio-analyysillä testatessa molemmat mallit suoriutuivat hyvin tuottojen selittämisessä, mutta vakiotermien perusteella kolmimomenttinen malli suoriutuisi paremmin. Regressiomallin ja artikkelin perusteella saadut betat olivat yhteneväisiä. Regressiomallin ja artikkelin perusteella saaduissa gam-moissa oli kuitenkin eroja ja niiden perusteella ei voida tehdä johtopäätöksiä. Regressiomalli näyttäisi kuitenkin huomioivan vinouden.

Stock and Bond Market Integration: Evidence from Russian Financial Markets

Minimizing the risks of an investment portfolio but not in the favour of expected returns is one of the key interests of an investor. Typically, portfolio diversification is achieved using two main strategies: investing in different classes of assets thought to have little or negative correlations or investing in similar classes of assets in multiple markets through international diversification. This study investigates integration of the Russian financial markets in the time period of January 1, 2003 to December 28, 2007 using daily data. The aim is to test the intra-country and cross-country integration of the Russian stock and bond markets between seven countries. Our test methodology for the short-run dynamics testing is the vector autoregressive model (VAR) and for the long-run cointegration testing we use the Johansen cointegration test which is an extension to VAR. The empirical results of this study show that the Russian stock and bond markets are not integrated in the long-run either at intra-country or cross-country level which means that the markets are relatively segmented. The short-run dynamics are also relatively low. This implies a presence of potential gains from diversification.

Study of B0(s)→K0Sh+h′− decays with first observation of B0s→K0SK±π∓ and B0s→K0Sπ+π

A search for charmless three-body decays of B 0 and B0s mesons with a K0S meson in the final state is performed using the pp collision data, corresponding to an integrated luminosity of 1.0 fb−1, collected at a centre-of-mass energy of 7 TeV recorded by the LHCb experiment. Branching fractions of the B0(s)→K0Sh+h′− decay modes (h (′) = π, K), relative to the well measured B0→K0Sπ+π− decay, are obtained. First observation of the decay modes B0s→K0SK±π∓ and B0s→K0Sπ+π− and confirmation of the decay B0→K0SK±π∓ are reported. The following relative branching fraction measurements or limits are obtained $ B(B0→K0SK±π∓)B(B0→K0Sπ+π−)=0.128±0.017(stat.)±0.009(syst.),B(B0→K0SK+K−)B(B0→K0Sπ+π−)=0.385±0.031(stat.)±0.023(syst.),B(B0s→K0Sπ+π−)B(B0→K0Sπ+π−)=0.29±0.06(stat.)±0.03(syst.)±0.02(fs/fd),B(B0s→K0SK±π∓)B(B0→K0Sπ+π−)=1.48±0.12(stat.)±0.08(syst.)±0.12(fs/fd)B(B0s→K0SK+K−)B(B0→K0Sπ+π−)∈[0.004;0.068]at90%CL.

Suivi thérapeutique pharmacologique des inhibiteurs de protéines kinases

La plupart des inhibiteurs de protéines kinases développés en nombre à la suite de l'imatinib partagent avec celui-ci les caractéristiques des médicaments candidats au suivi thérapeutique pharmacologique : importante variabilité pharmacocinétique entre patients, influences de traits pharmacogénétiques et d'atteintes d'organes, potentiel d'interactions médicamenteuses, relations stables entre exposition et efficacité ou toxicité, index thérapeutique restreint. Alors que le profilage génétique des tumeurs ouvre la voie vers une oncologie personnalisée quant au choix des molécules thérapeutiques, le monitoring des concentrations et l'individualisation des posologies devraient assurer que chaque patient est exposé aux concentrations lui garantissant la meilleure efficacité pour le minimum de toxicité. Pour cela, il faut d'abord disposer d'études observationnelles décrivant la pharmacocinétique de population du médicament et les concentrations attendues sous une posologie donnée. Des études pharmacodynamiques doivent aussi déterminer les relations concentration-efficacité-toxicité, dont découlent les cibles d'exposition à viser par le traitement. Sur ces bases, une stratégie rationnelle de monitoring peut être élaborée, puis testée dans des essais cliniques randomisés contrôlés. Les progrès se font attendre dans ce domaine, en raison non seulement du désintérêt des groupes pharmaceutiques, des cliniciens et des autorités, mais aussi des difficultés inhérentes au processus de suivi des concentrations, tel qu'il se pratique aujourd'hui. Des innovations technologiques associant des méthodes de mesure miniaturisées intégrées à des systèmes électroniques et une connexion à des outils informatiques d'assistance à l'interprétation pourraient prochainement mettre ce monitoring à la disposition immédiate des oncologues sur le lieu de consultation.